1190620-43-9

Basic information

• Product Name: 4,6-bis(4-fluorophenyl)-8,15-dihydro-1H-quinolino[8′,1′:2,3,4][1,4]-oxazocino[6,7-b]quinoxalin-1-one
• Synonyms: 4,6-bis(4-fluorophenyl)-8,15-dihydro-1H-quinolino[8′,1′:2,3,4][1,4]-oxazocino[6,7-b]quinoxalin-1-one
• CAS NO: 1190620-43-9
• Molecular Weight: 503.508
• Mol File: 1190620-43-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4,6-bis(4-fluorophenyl)-8,15-dihydro-1H-quinolino[8′,1′:2,3,4][1,4]-oxazocino[6,7-b]quinoxalin-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 4,6-bis(4-fluorophenyl)-8,15-dihydro-1H-quinolino[8′,1′:2,3,4][1,4]-oxazocino[6,7-b]quinoxalin-1-one(1190620-43-9)
• EPA Substance Registry System: 4,6-bis(4-fluorophenyl)-8,15-dihydro-1H-quinolino[8′,1′:2,3,4][1,4]-oxazocino[6,7-b]quinoxalin-1-one(1190620-43-9)

Safety Data

• Hazardous Substances Data: 1190620-43-9(Hazardous Substances Data)

Upstream product

• 1182708-31-1 5,7-dibromoquinolonoquinoxalino-oxazocine 
• 1765-93-1 4-fluoroboronic acid 
• 3138-86-1 2,3-bis(bromomethyl)quinoxaline 
• 521-74-4 broxyquinoline 

Relevant articles and documents

Combined palladium/eosin Y-catalysed direct synthesis of anticancer biarylquinolinooxazocino-quinoxaline-1-ones under visible light in one-pot sequence: a revisited proof of concept

Abstract: A novel, efficient, and green catalytic system under visible light irradiation has been introduced for the synthesis of anticancer biarylquinolooxazocino-quinoxaline-1-ones in one-pot sequence. The developed synthetic approach will be successfully utilized for the synthesis of various bioactive biarylquinolone in near future. Also, the cytotoxicity profile of these scaffolds has unveiled their superb cytoselectivity in HeLa and MCF-7 cell line compared to cisplatin. Graphic abstract: [Figure not available: see fulltext.]